XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Schedule of Common Stock Outstanding (Details) - shares
Sep. 22, 2023
Dec. 31, 2023
Business Acquisition [Line Items]    
Total - Conduit Pharmaceuticals Inc. common stock outstanding as a result of Business Combination, PIPE Financing, exchange of Conduit Pharmaceuticals Limited shares for shares of Conduit Pharmaceuticals Inc., issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes, and transaction services agreements, shares   73,829,536
Murphy Canyon Acquisition Corp [Member]    
Business Acquisition [Line Items]    
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares 54,000  
Murphy Canyon Acquisition Corp [Member] | Conduit Pharmaceuticals Inc [Member]    
Business Acquisition [Line Items]    
Total - Conduit Pharmaceuticals Inc. common stock outstanding as a result of Business Combination, PIPE Financing, exchange of Conduit Pharmaceuticals Limited shares for shares of Conduit Pharmaceuticals Inc., issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes, and transaction services agreements, shares 72,418,316  
Murphy Canyon Acquisition Corp [Member] | Subscription Agreements [Member]    
Business Acquisition [Line Items]    
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares 2,000,000  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member]    
Business Acquisition [Line Items]    
Business Combination, net of redemptions, shares 4,118,316  
Exchange of Conduit Pharmaceuticals Limited ordinary shares for Conduit Pharmaceuticals Inc. common stock on the Closing Date, shares 32,313.215  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Conduit Pharmaceuticals Inc [Member]    
Business Acquisition [Line Items]    
Exchange of Conduit Pharmaceuticals Limited ordinary shares for Conduit Pharmaceuticals Inc. common stock on the Closing Date, shares 64,626,430  
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the transaction, shares 1,300,000  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Subscription Agreements [Member]    
Business Acquisition [Line Items]    
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares 2,000,000  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Sponsor [Member]    
Business Acquisition [Line Items]    
Business Combination, net of redemptions, shares 4,015,250  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Director [Member]    
Business Acquisition [Line Items]    
Business Combination, net of redemptions, shares 45,000  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Conduit Convertible Note Holders [Member]    
Business Acquisition [Line Items]    
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares 373,570  
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Common Stock Subject to Mandatory Redemption [Member]    
Business Acquisition [Line Items]    
Business Combination, net of redemptions, shares 58,066